Literature DB >> 30120902

Cancer After Liver Transplantation in Children and Young Adults: A Population-Based Study From 4 Nordic Countries.

Fredrik Åberg1, Helena Isoniemi1, Eero Pukkala2,3, Hannu Jalanko4, Allan Rasmussen5, Hans H Storm6, Nicolai Schultz5, William Bennet7, Nils Ekvall8, Bo-Göran Ericzon9, Silvia Malenicka10, Steinar Tretli11, Pål-Dag Line12,13, Kirsten Muri Boberg12,13,14, Anniken Østensen13,15, Tom Hemming Karlsen12,13,14,16, Arno Nordin1.   

Abstract

Cancer after liver transplantation (LT) constitutes a threat also for young recipients, but cancer risk factors are usually absent in children and large studies on the cancer risk profile in young LT recipients are scarce. Data of patients younger than 30 years who underwent LT during the period 1982-2013 in the Nordic countries were linked with respective national cancer registries to calculate standardized incidence ratios (SIRs). A total of 37 cancer cases were observed in 923 patients with 7846 person-years of follow-up. The SIR for all cancer types, compared with the matched general population, was 9.8 (12.4 for males and 7.8 for females). Cumulative incidence of cancer adjusted for the competing risk of death was 2% at 10 years, 6% at 20 years, and 22% at 25 years after LT. Non-Hodgkin lymphoma was the most common cancer type (n = 14) followed by colorectal (n = 4) and hepatocellular cancer (n = 4). Age was a significant risk factor for cancer, and the absolute risk of most cancers (except for lymphoma) increased considerably in young adults older than 20 years. The cancer risk pattern is different in pediatric and young LT patients compared with adult recipients. The striking increase in cancer incidence in young adulthood after the second decade of life deserves further consideration in transition programs.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 30120902     DOI: 10.1002/lt.25305

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Improvements in Disease-Specific Health-Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal.

Authors:  Saeed Mohammad; Shikha S Sundaram; Kristen Mason; Steven Lobritto; Mercedes Martinez; Yumirle P Turmelle; John Bucuvalas; Sandy Feng; Estella M Alonso
Journal:  Liver Transpl       Date:  2021-05       Impact factor: 5.799

2.  Synovial Cell Sarcoma in an Adolescent Liver Transplant Recipient.

Authors:  Catalina Jaramillo; Ahmed Gilani; Mary Haag; Nathan Donaldson; Cara Mack
Journal:  ACG Case Rep J       Date:  2019-05-16

3.  Cancer morbidity and mortality after pediatric solid organ transplantation-a nationwide register study.

Authors:  Kira Endén; Juuso Tainio; Atte Nikkilä; Ilkka Helanterä; Arno Nordin; Mikko P Pakarinen; Hannu Jalanko; Kirsi Jahnukainen; Timo Jahnukainen
Journal:  Pediatr Nephrol       Date:  2020-05-11       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.